Poway, CA (PRWEB) July 18, 2013
Vet-Stem, Inc., a biotechnology company that develops and markets revolutionary products in the field of Veterinary Regenerative MedicineTM, announced that Chief Executive Officer Robert J. Harman, DVM presented this week at the Case Western Reserve University meeting “The Business of Regenerative Medicine: From Stem Cells to the Market Place” in Cleveland, Ohio. Dr. Harman has been a regular presenter at this prestigious meeting, providing insights into the commercialization of stem cell technology in the veterinary field.
Dr. Harman spoke as part of the New Leadership in Regenerative Medicine Session describing the outcomes and business metrics from more than 10,000 horse, dog and cat patients treated over the last 10 years in both the U.S. and Canada using proprietary Vet-Stem technology. Dr. Harman, the only presenter from the veterinary field, presented along with more than 20 other leading companies in the regenerative medicine field. The CEOs of OSIRIS, BioTime, Mesoblast and the Directors of the Harvard Stem Cell Institute, and Genetics Policy Institute, along with many other global leaders also spoke.
Arnold I. Caplan, PhD, the meeting organizer and technology pioneer in cell-based therapies in Regenerative Medicine, is a scientific advisor to Vet-Stem, Inc.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veteri
Copyright©2012 Vocus, Inc.
All rights reserved